Technology
The Artida is reportedly the first ultrasound system with the ability to track and display myocardial motion and 3D volumes in 3D images. Two and 3D wall motion tracking features allow the user to obtain angle-independent, quantitative and regional information about myocardial contraction.
February 10, 2008
News
February 11, 2008 - The first patient was successfully treated in AtriCure’s ABLATE clinical trial designed to evaluate ...
February 10, 2008
Technology
Toshiba's Vantage Titan MRI is designed to capture higher resolution heart images, while capturing deeper imaging of the anatomy. This is possible due to the center eight elements of the cardiac coils being smaller and the outer eight elements of the cardiac coils being larger on the Vantage Titan according to Toshiba.
February 10, 2008Sponsored Content
Feature | Thrombectomy Devices
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026News
February 11, 2008 - Battlefield Imaging of Ringgold, GA, has become the first facility in the U.S. to install the MAGNETOM ESSENZA magnetic resonance imaging (MRI) system from Siemens Healthcare, designed to be an affordable 1.5 Tesla system.
February 10, 2008News
February 11, 2008 - Leman Cardiovascular’s animal studies to evaluate the performance in both the aortic and mitral ...
February 10, 2008Technology
Emageon's HeartSuite offers cardiovascular information management, hemodynamic monitoring, advanced visualization and content management. Emageon’s architecture combines HeartSuite with radiology and other medical specialties designed to offer a comprehensive patient–centric view of the visual medical record. One suite of integrated, enterprise cardiology tools includes:
February 07, 2008Sponsored Content
Feature | Cardiac Imaging
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 13, 2026News
February 8, 2008 – CryoLife Inc. said it received FDA 510(k) clearance for its CryoValve SG pulmonary human heart valve ...
February 07, 2008News
February 8, 2008 - Emageon received first place in the “Best in KLAS” Top 20 Report for the Cardiology PACS nomination ...
February 07, 2008Technology
CryoLife Inc.'s CryoValve SG pulmonary human heart valve is processed with the company’s proprietary SynerGraft technology, providing a valve replacement option for children born with heart defects or for replacement surgery.
February 07, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
February 7, 2008 - Volcano Corp. said the FDA cleared the s5-Revo and s5-FFR (fractional flow reserve) options, enabling ...
February 07, 2008News
February 8, 2008 - CryoLife Inc. received 510(k) clearance from the FDA for its CryoValve SG pulmonary human heart valve processed with the company’s proprietary SynerGraft technology, providing a valve replacement option for children born with heart defects or for replacement surgery.
February 07, 2008Technology
February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access phased Array IVUS, Rotational IVUS and integrated FFR on the same integrated IVUS platform.
February 07, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access phased Array IVUS, Rotational IVUS and integrated FFR on the same integrated IVUS platform.
February 07, 2008
Technology
McKesson’s ECG Management module, a component of Horizon Cardiology, is a fully integrated, Web-enabled ...
February 06, 2008News
February 7, 2008 - Tryton Medical Inc.’s Side Branch Stent obtains CE Mark approval based on results in the Tryton 1 (First-in-Man Study) with No Side-Branch Restenosis in 30 patients, according to the manufacturer.
February 06, 2008